TDM BERHAD — Earnings Release 2026

May 17, 2026

TDM

MEDIA RELEASE

FOR IMMEDIATE RELEASE

TDM Berhad

Registration No.: 196501000477 (6265-P)

Wisma TDM, 443D, Jalan Kamaruddin,

20400 Kuala Terengganu, Terengganu

Tel: +609-620 4800

Fax: +609-620 4803

TDM BERHAD REPORTS Q1 FY2026 RESULTS WITH STRONG REVENUE GROWTH, FOCUS ON OPERATIONAL EFFICIENCY AMID MARGIN PRESSURES

Key Highlights:

• Plantation Division: Volume-Led Growth Amid Price Pressures
• Healthcare Division: Resilient Growth Backed by Higher Patient Volumes

Kuala Terengganu, 18 May 2026 –TDM Berhad ("TDM" or "the Group") today announced its financial results for the first quarter ended FY2026 ("Q1 FY2026"), recording a solid 34% year-on-year increase in revenue to RM174.5 million, compared to RM130.2 million in the corresponding quarter last year, driven by improved contributions from both its Plantation and Healthcare divisions.

Despite the stronger top-line performance, the Group reported a loss before tax ("LBT") of RM8.9 million. The Group has narrowed its loss from RM22.4 million previously, mainly due to margin compression in the Plantation division and higher operating costs. Nonetheless, the Group's EBITDA rose significantly by 16.6 times year-on-year to RM15.3 million, reflecting improved operational performance across its core segments.

	Quarter Ended
	Q1 FY2026 RM'000	Q1 FY2025 RM'000	Variance RM'000	Variance %
Revenue:
Plantation	84,318	49,609	34,709	70
Healthcare	90,221	80,566	9,655	12
Investment holding and others	-	-	-	-
Total Revenue	174,539	130,175	44,364	34
(LBT)/PBT:
Plantation	(4,188)	(12,313)	8,125	66
Healthcare	1,653	(771)	2,424	>100
Investment holding and others	(6,360)	(9,379)	3,019	32
Share of results of associate	38	42	(4)	(10)
Total LBT	(8,857)	(22,421)	13,564	60
EBITDA:
Plantation	11,540	3,250	8,290	>100
Healthcare	6,930	4,170	2,760	66
Investment holding and others	(3,187)	(6,539)	3,352	51
Share of results of associate	38	42	(4)	(10)
Total EBITDA	15,321	923	14,398	>100

---

2/ TDM BERHAD REPORTS Q1 FY2026 RESULTS WITH STRONG REVENUE GROWTH, FOCUS ON OPERATIONAL EFFICIENCY AMID MARGIN PRESSURES (CONT'D.)

Commenting on the results, Tuan Haji Najman Kamaruddin, Group Chief Executive Officer of TDM Berhad, said: "Q1 FY2026 marks a strong start in terms of revenue growth, particularly within our Plantation division where production volumes rebounded significantly. While profitability was impacted by softer commodity prices and cost pressures, we are encouraged by the improvement in EBITDA, which reflects the underlying strength of our operations. Our Healthcare division continues to demonstrate resilience with steady growth in patient volumes and service capacity. Moving forward, we will remain focused on enhancing operational efficiency, managing costs prudently, and strengthening our core businesses to navigate ongoing market challenges."

Malaysia Plantation Division

The Plantation division recorded a strong 70% increase in revenue to RM84.3 million, underpinned by higher sales volumes. Crude palm oil ("CPO") and palm kernel ("PK") sales volumes rose by 93% and 97% respectively, in line with a 56% increase in fresh fruit bunch ("FFB") production. However, the division reported a loss before tax of RM4.2 million, a huge improvement compared to a loss before tax of RM12.3 million in the same quarter last year. Despite this, EBITDA improved markedly to RM11.5 million or by 3.5 times, supported by higher production and better extraction rates.

Malaysia's CPO production in Q1 FY2026 declined 27% quarter-on-quarter ("QoQ") to 4.24 million mt but increased 11% year-on-year ("YoY"), with March 2026 output rebounding 7% after prior declines. Exports stood at 3.18 million mt, down 3% QoQ but up 29% YoY, supported by a strong 41% surge in March 2026. As a result, palm oil stocks fell 26% to 2.27 million mt at end-March, although remaining 45% higher YoY. The average CPO price declined 12% YoY to RM4,152 per mt, despite a sharp recovery in March. Inventory levels are expected to trend lower towards 2.0 million mt amid firm global demand.

Healthcare Division

The Healthcare division posted revenue of RM90.2 million, representing a 12% increase year-on-year, driven by higher patient volumes and improved service delivery. Inpatient admissions rose by 5% while outpatient visits increased by 7%, alongside improvements in inpatient days and occupancy rates.

The division recorded a PBT of RM1.7 million as compared to a loss before tax ("LBT") of RM0.8 million in the corresponding quarter of the preceding year. In addition, EBITDA grew by 66% to RM6.9 million, reflecting the stronger operational efficiency and better cost absorption arising from higher utilisation levels.

It is anticipated that the Group will pursue its steady growth trend in the next quarters. Continued government support serves as fundamental drive for the economic growth despite the escalating geopolitical tensions in the Middle East. Challenges are continuing to persist especially in terms of fuel and energy costs which have a direct impact on multiple level of operational costs. Further reduction of rebate for electricity cost under the Automatic Fuel Adjustment (AFA) shall lead to higher bills and subsequently put a strain on the existing operational cost structure. The anticipated Diagnosis-Related Groups (DRGs) commencement in January 2027 shall also provide better transparency and further improve the value-based healthcare level. The Group fully supports the digital health initiative by the Ministry of Health towards reducing the healthcare treatment costs as part of intensified efforts for public well-being.

---

3/ TDM BERHAD REPORTS Q1 FY2026 RESULTS WITH STRONG REVENUE GROWTH, FOCUS ON OPERATIONAL EFFICIENCY AMID MARGIN PRESSURES (CONT'D.)

Divestment of Plantation Indonesia Division

The Conditional Share Purchase Agreement ("CSPA") for the disposal of PT Rafi Kamajaya Abadi ("PT RKA") and PT Sawit Rezki Abadi ("PT SRA") was signed between TDM and Ikhasas Sawit Sdn. Bhd. on the 29 July 2022. PT RKA continues to be fully managed by PT Ikhasas Sawit Indo Makmur through a management services arrangement starting 1 August 2022.

As per announcement to Bursa Malaysia on 12 January 2026, the fulfilment of Condition Precedents has been extended to Long Stop Date of 30 June 2026 ("Sixth Extended Long Stop Date"). Both TDM and the Buyer remain committed to seeing the completion of the disposal.

END

About TDM Berhad

Incorporated in 1965, TDM Berhad is one of the Shariah-compliant securities listed on the Main Market of Bursa Malaysia's with core businesses in oil palm plantation and healthcare services.

The Group's plantation arm, TDM Plantation Sdn. Bhd. (TDMP) is a premium producer of Certified Sustainable Palm Oil (CSPO) and Certified Sustainable Palm Kernel (CSPK) with the Malaysian Sustainable Palm Oil (MSPO) and Roundtable on Sustainable Palm Oil (RSPO). It manages 13 oil palm estates and two (2) palm oil mills, two (2) Bio-Composting plants and two (2) Biogas plants located in Terengganu.

Under Kumpulan Medic Iman Sdn. Bhd. (KMI Healthcare), TDM owns five (5) community specialist hospitals that provide quality and affordable secondary healthcare services. The hospitals are KMI Kelana Jaya Medical Centre, Petaling Jaya, Selangor, KMI Kuantan Medical Centre, Kuantan, Pahang, KMI Kuala Terengganu Medical Centre, Kuala Terengganu, KMI Taman Desa Medical Centre, Kuala Lumpur and KMI Tawau Medical Centre, Sabah.

For further details, please visit our website www.tdmberhad.com.my

Contact Person:

Norfar'izan Hashim

Corporate Communication Department

Telephone No.: +609 6204800 / +6019 9155401

Fax: +609 6204803

Email: norfarizan.hldg@tdmberhad.com.my